RAD51 and breast cancer: At the germline level, some studies have shown that the single nucleotide polymorphism (SNP) −135G>C (rs1801320) in the 5′ untranslated region (UTR) of RAD51 modifies breast cancer risk in BRCA2 mutation carriers but not in BRCA1 mutation carriers [23], [24].